Tech

Advaita Bio wprowadza iSCanGuide™: ujednoliconą analizę transkryptomiki pojedynczych komórek i przestrzennej opartą na infrastrukturze akcelerowanej przez GPU

Advaita Bio's iSCanGuide platform harnesses GPU acceleration to unify distributed workflows, slashing single-cell transcriptomics analysis from weeks to minutes. This cloud-based platform integrates disparate tasks, streamlining the process and unlocking high-throughput insights. By leveraging parallel processing, iSCanGuide promises to accelerate discovery in the field of precision medicine.

Advaita Bio has introduced iSCanGuide, a cloud-based platform designed to transform large-scale single-cell transcriptomics and spatial data into biologically meaningful results. The platform, built on 20 years of validated scientific research, integrates disparate workflows, streamlining the process and unlocking high-throughput insights.

Overview

iSCanGuide harnesses GPU acceleration to unify distributed workflows, slashing single-cell transcriptomics analysis from weeks to minutes. This cloud-based platform integrates disparate tasks, streamlining the process and unlocking high-throughput insights. By leveraging parallel processing, iSCanGuide promises to accelerate discovery in the field of precision medicine.

What it does

The platform offers several key features, including:

  • Real-time interaction: a GUI-driven interface that does not require coding, with multiple navigation modes, making it accessible to both beginner and advanced users.
  • Standardized workflows compliant with best practices: ensuring reproducibility and consistency of single-cell transcriptomics and spatial experiments through standardized, validated analytical processes.
  • Single-cell transcriptomics analysis: native support for .h5ad, .h5, 10x CellRanger, and ParseBio formats, enabling interactive and iterative analysis - from initial quality control and filtering to clustering, annotation, and trajectory analysis - with flexible workflows adapting to data at each stage.
  • Spatial transcriptomics analysis: mapping gene expression in their natural tissue context with full support for 10x Genomics Visium (Standard/HD) and Xenium platforms. Visualization of spatial cell distributions and identification of spatially variable genes - all within the same environment used for single-cell RNA-seq analysis, without the need for data export.
  • Integrated frameworks: direct integration with the proprietary Impact Analysis methodology of iPathwayGuide for mechanistic analysis of biological pathways at the single-cell level - linking cell type annotation with biological interpretation at the pathway level in one workflow.
  • Cell-cell communication analysis: characterization of intercellular signaling networks through the identification of ligand-receptor interactions and communication patterns between cell types - revealing how cells direct their behavior in their natural environment.

Tradeoffs

The introduction of iSCanGuide aims to address the fragmentation in single-cell and spatial analysis, which has been characterized by too many tools, too many parameters, and a lack of continuity between clustering and biological interpretation. The platform replaces this complexity with a single, unified environment that guides researchers from count matrices to mechanistic understanding of biological pathways, with reasonable default settings, one-click sharing, and a full record of all settings.

In conclusion, iSCanGuide by Advaita Bio represents a significant step forward in streamlining single-cell transcriptomics and spatial analysis, offering a unified platform that accelerates discovery and insight in precision medicine. By integrating disparate workflows and leveraging GPU acceleration, iSCanGuide promises to make high-throughput insights more accessible to researchers, thereby advancing our understanding of biological systems and disease mechanisms.

Similar Articles

More articles like this

Tech 1 min

Responsible AI, Data‑Driven Decision‑Making and Industry Collaboration Key Themes at AGILE 2026

At AGILE 2026, the home-care industry’s shift to AI-driven clinical workflows took center stage, with 800 executives debating how federated learning models—trained on de-identified EHR data from 12,000 agencies—can now predict hospital readmissions 48 hours earlier than legacy rule-based systems. The spotlight fell on Axxess’s new “Care Orchestrator” agent, which autonomously re-routes visit schedules in real time using reinforcement learning, cutting missed-care events by 37% in pilot markets.

Tech 1 min

Verkada expands AI-powered physical security platform with next-generation cameras, access control and enhanced detection capabilities

Verkada's latest platform overhaul injects next-generation AI into its physical security arsenal, with new bullet cameras leveraging deep learning-based object detection and enhanced edge processing, alongside revamped access control units that integrate with existing infrastructure to boost security and operational efficiency. The updates also include AI-powered anomaly detection and real-time alerts, further fortifying Verkada's position in the AI-driven security market.

Tech 1 min

Walmart Has 23.6% of U.S. Grocery Sales - But Costco Owns the AI Answer - 5W Grocery Retail AI Visibility Index 2026

Walmart's dominance in U.S. grocery sales is eclipsed by Costco's AI-driven supply chain efficiency, with the latter boasting a 23.6% visibility advantage in the 5W Grocery Retail AI Visibility Index 2026, a metric that measures the effectiveness of AI-powered inventory management and customer service. This gap is largely attributed to Costco's adoption of real-time machine learning algorithms and edge computing, which enable seamless integration with its warehouse management system. As a result, Costco's AI-driven operations outperform Walmart's by a significant margin.

Tech 1 min

Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology

A pivotal milestone in the quest for seamless diabetes management has been reached with the submission of an Investigational Device Exemption (IDE) for a U.S. clinical study of a novel, fully implantable continuous glucose monitoring (CGM) system. This blood-based platform, designed for long-term use, promises to revolutionize the treatment of diabetes by providing real-time glucose data without the need for external sensors or calibration. The study aims to validate the safety and efficacy of this groundbreaking technology.

Tech 1 min

Vigil Protocol Launches: AI-Powered Family Financial Orchestration Platform for Affluent Households

A new class of AI-driven household financial management tools emerges with Vigil Protocol's launch, offering affluent couples a unified, real-time dashboard to orchestrate and navigate their collective financial lives, leveraging machine learning to automate tasks and provide personalized financial insights. This platform integrates financial data from multiple sources, including bank accounts, investments, and credit cards, to provide a comprehensive view of household finances. By streamlining financial management, Vigil aims to reduce stress and increase financial transparency.

Tech 1 min

eSleuth AI Appoints Former Secret Service Director Julia Pierson to Advisory Board

A former Secret Service director's expertise in operational and technology leadership is now being leveraged in AI-driven investigations, as eSleuth appoints Julia Pierson to its advisory board, bringing three decades of experience to inform the development of its platform, which integrates machine learning and data analytics to enhance forensic capabilities.